Analysis of Clinical Characteristics and the Effect of Symptomatic Supportive Treatment for Severe Neonatal Enterovirus Infection

重症新生儿肠道病毒感染的临床特征分析及对症支持治疗效果

阅读:2

Abstract

OBJECTIVE: To retrospectively analyze cases of neonatal enterovirus (EV) infection, identify risk factors for severe infection, pathological characteristics, and prognostic differences, and provide a basis for early identification of high-risk neonates. METHODS: Neonates diagnosed with EV infection and admitted to Zhuzhou Central Hospital between January 2020 and December 2023 were included in the study. Based on disease severity, they were divided into a mild infection group (n = 149) and a severe infection group (n = 44). Data on demographic characteristics, clinical manifestations, laboratory findings, treatment methods, and prognosis were collected and statistically analyzed using SPSS 26.0. RESULTS: Compared to the mild infection group, the severe infection group had lower gestational age (36.61 vs 38.50 weeks, P < 0.001) and higher preterm birth rates (P < 0.05). They presented earlier with higher incidences of rash, respiratory symptoms, and sepsis-like signs (all P < 0.05). Severe cases had significantly higher rates of pneumonia, myocarditis, necrotizing hepatitis, and DIC (all P < 0.001), with a mortality rate of 54.55% (P < 0.001). Laboratory findings showed more thrombocytopenia, coagulation dysfunction, and organ injury markers in the severe group (all P < 0.001). Mild cases required mainly non-invasive treatment, while severe cases had high mortality despite intensive interventions. Among survivors, 50% required long-term neurological rehabilitation. CONCLUSION: Severe neonatal EV infection is closely associated with preterm birth and perinatal infection, characterized by thrombocytopenia, coagulation dysfunction, and multiple organ damage. Early monitoring of high-risk neonates, especially preterm infants, should be reinforced. For neonates presenting within the first seven days of life with rash or respiratory distress accompanied by a rapid decline in platelet count, intensive care should be promptly initiated. Further research is needed to explore targeted antiviral therapies and immune modulation strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。